The negative effects of TGF-β on cancer immune surveillance have been well studied, including impairing immune infiltration, inducing the differentiation toward MDSC/M2-like macrophage/Treg, limiting the cytotoxicity of T cell and NK cell, and undermining the antigen presentation capability of DC. The gene discussed is TGFB1; the disease is cancer.